Blood neurofilament light levels are lowered to a healthy donor range in patients with RMS and PPMS following ocrelizumab treatmentA. Bar-Or, G-A. Thanei,C. T. Harp,A. H. Cross,S. L. Hauser,J. Kuhle,D. Leppert,J. Oksenberg,F. Model,D. Fiore,H. Koendgen,L. Mehta,R. Hendricks,S. Fischer,M. Manfrini,A. E. HermanMULTIPLE SCLEROSIS JOURNAL（2019）引用 19|浏览23暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
